Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001437749-23-011369
Filing Date
2023-04-27
Accepted
2023-04-27 16:17:30
Documents
15
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A govx20221231_10ka.htm   iXBRL 10-K/A 261547
2 EXHIBIT 31.3 ex_505016.htm EX-31.3 6341
3 EXHIBIT 31.4 ex_505017.htm EX-31.4 6236
  Complete submission text file 0001437749-23-011369.txt   526529

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA govx-20221231.xsd EX-101.SCH 4061
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE govx-20221231_def.xml EX-101.DEF 18786
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE govx-20221231_lab.xml EX-101.LAB 25049
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE govx-20221231_pre.xml EX-101.PRE 19523
9 EXTRACTED XBRL INSTANCE DOCUMENT govx20221231_10ka_htm.xml XML 9695
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

EIN.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39563 | Film No.: 23857209
SIC: 2834 Pharmaceutical Preparations